Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Oza, Amit, Cook, Adrian D, Pfisterer, Jacobus, Embleton, Andrew, Ledermann, Jonathan A., Pujade-lauraine, Eric, Kristensen, Gunnar, Carey, Mark S, Beale, Philip, Cervantes, Andrés, Park-Simon, Tjoung-Won, Rustin, Gordon Js, Joly, F, Mirza, Mansoor R., Plante, Marie, Quinn, Michael, Poveda, Andres, Jayson, Gordon C, Stark, Dan, Swart, Ann Marie ORCID: https://orcid.org/0000-0002-9359-6995, Farrelly, Laura, Kaplan, Richard S, Parmar, Mahesh K.b. and Perren, Timothy J. (2015) Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. The Lancet Oncology, 16 (8). 928–936. ISSN 1470-2045

Preview

PDF (ICON7 OS results Lancet 2015) - Published Version Available under License Creative Commons Attribution. Download (415kB) | Preview

Item Type:	Article
Uncontrolled Keywords:	sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Depositing User:	Pure Connector
Date Deposited:	24 Jul 2015 23:03
Last Modified:	21 Oct 2022 01:02
URI:	https://ueaeprints.uea.ac.uk/id/eprint/53798
DOI:	10.1016/S1470-2045(15)00086-8

Downloads

Actions (login required)

View Item